Gyre Therapeutics (GYRE) Debt to Equity (2010 - 2016)
Gyre Therapeutics (GYRE) reported Debt to Equity of $0.0 for Q3 2016, down 92.35% year-over-year from $0.02 in Q4 2015, and down 74.2% quarter-over-quarter from $0.01 in Q2 2016.
Gyre Therapeutics (GYRE) Debt to Equity (2010 - 2016) Analysis & Trends
Gyre Therapeutics (GYRE) has 7 years of Debt to Equity data on file, last reported at $0.0 in Q3 2016.
- Debt to Equity for Q3 2016 came in at $0.0, down 92.35% year-over-year; the trailing twelve-month figure through Sep 2016 was $0.0 (down 92.35% YoY), and the FY2015 annual result was $0.04, changed N/A from the prior year.
- Debt to Equity eased to $0.0 in Q3 2016 per GYRE's latest filing, from $0.01 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.04 in Q4 2015 and troughed at -$0.02 in Q4 2012.
- A 5-year average of $0.01 and a median of $0.01 in 2014 frame the typical range for Debt to Equity.
- The sharpest annual moves came in 2012 and 2015: Debt to Equity tumbled 214.97% in 2012, then surged 341.03% in 2015.
- A 5-year view of Debt to Equity shows it stood at -$0.02 in 2012, then surged by 48.19% to -$0.01 in 2013, then soared by 138.39% to $0.0 in 2014, then jumped by 768.93% to $0.04 in 2015, then plunged by 96.12% to $0.0 in 2016.
- Business Quant data shows GYRE's Debt to Equity at $0.0 in Q3 2016, $0.01 in Q2 2016, and $0.01 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 0.00 |
| Jun 30, 2016 | 0.01 |
| Mar 31, 2016 | 0.01 |
| Dec 31, 2015 | 0.04 |
| Sep 30, 2015 | 0.02 |
| Sep 30, 2014 | 0.00 |
| Jun 30, 2014 | 0.01 |
| Mar 31, 2014 | 0.01 |
| Dec 31, 2013 | -0.01 |
| Sep 30, 2013 | 0.01 |
| Jun 30, 2013 | 0.01 |
| Mar 31, 2013 | 0.01 |
| Dec 31, 2012 | -0.02 |
| Sep 30, 2012 | 0.01 |
| Jun 30, 2012 | 0.01 |
| Mar 31, 2012 | 0.01 |
| Dec 31, 2011 | 0.02 |
| Sep 30, 2011 | 0.02 |
| Jun 30, 2011 | 0.02 |
| Dec 31, 2010 | 0.03 |